Patients affected by aggressive neoplasms with a high propensity to metastasize to the skin, such as some head and neck cancers, can benefit from electrochemotherapy, a modality that combines electroporation of cell membranes and chemotherapy to facilitate the transport of non-permeant molecules into cells; the host immune response consequently participates in achieving cure of tumors. Electrochemotherapy (A) can be successfully used for skin metastases of head and neck tumors and, with some limitations, for primary and relapsing neoplasms; (B) can be applied on an outpatient basis with a favourable cost-benefit ratio; (C) is a repeatable treatment that, if necessary, can be followed by traditional antineoplastic therapies. Although still a palliative treatment, the good level of tolerability and the high success rates of electrochemotherapy make it worth consideration among treatment options in selected patients.

Electrochemotherapy in head and neck cancer: a review of an emerging cancer treatment / De Virgilio, A; Ralli, M; Longo, L; Mancini, P; Attanasio, Giuseppe; Atturo, F; de Vincentiis, M; Greco, A. - In: ONCOLOGY LETTERS. - ISSN 1792-1074. - STAMPA. - 16:3(2018), pp. 3415-3423. [10.3892/ol.2018.9140]

Electrochemotherapy in head and neck cancer: a review of an emerging cancer treatment

De Virgilio A
Primo
;
Ralli M
Secondo
;
Longo L;Mancini P;Attanasio;Atturo F;de Vincentiis M
Penultimo
;
Greco A
Ultimo
2018

Abstract

Patients affected by aggressive neoplasms with a high propensity to metastasize to the skin, such as some head and neck cancers, can benefit from electrochemotherapy, a modality that combines electroporation of cell membranes and chemotherapy to facilitate the transport of non-permeant molecules into cells; the host immune response consequently participates in achieving cure of tumors. Electrochemotherapy (A) can be successfully used for skin metastases of head and neck tumors and, with some limitations, for primary and relapsing neoplasms; (B) can be applied on an outpatient basis with a favourable cost-benefit ratio; (C) is a repeatable treatment that, if necessary, can be followed by traditional antineoplastic therapies. Although still a palliative treatment, the good level of tolerability and the high success rates of electrochemotherapy make it worth consideration among treatment options in selected patients.
2018
electrochemotherapy; electroporation; head and neck cancer; immune response; skin metastasis
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Electrochemotherapy in head and neck cancer: a review of an emerging cancer treatment / De Virgilio, A; Ralli, M; Longo, L; Mancini, P; Attanasio, Giuseppe; Atturo, F; de Vincentiis, M; Greco, A. - In: ONCOLOGY LETTERS. - ISSN 1792-1074. - STAMPA. - 16:3(2018), pp. 3415-3423. [10.3892/ol.2018.9140]
File allegati a questo prodotto
File Dimensione Formato  
De Virgilio_Electrochemotherapy in head_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 722.17 kB
Formato Adobe PDF
722.17 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1135730
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 25
social impact